Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT

Assertio Therapeutics (ASRT) Financial Statements

1,030 Followers

Assertio Therapeutics Financial Overview

Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.953; its P/E ratio is -0.37; Assertio Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 32.45M$ 32.98M$ 35.63M$ 40.99M$ 42.47M
Gross Profit$ 21.27M$ 23.26M$ 28.57M$ 36.22M$ 42.47M
EBIT$ -3.62M$ -31.25M$ -228.13M$ 13.08M$ -4.47M
EBITDA$ 2.18M$ -26.35M$ -217.67M$ 19.66M$ 2.16M
Net Income Common Stockholders$ -4.51M$ -57.38M$ -279.54M$ 8.47M$ -3.48M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.74M$ 73.44M$ 76.89M$ 70.17M$ 68.60M
Total Assets$ 281.96M$ 286.42M$ 380.03M$ 405.18M$ 414.27M
Total Debt$ 38.62M$ 38.51M$ 38.87M$ 38.25M$ 38.62M
Net Debt$ -42.12M$ -34.93M$ -38.02M$ -31.92M$ -29.98M
Total Liabilities$ 147.47M$ 148.42M$ 187.16M$ 150.91M$ 163.61M
Stockholders Equity$ 134.49M$ 138.00M$ 192.87M$ 254.27M$ 250.66M
Cash Flow-
Free Cash Flow$ 7.51M$ 5.89M$ 2.58M$ 17.90M$ 22.61M
Operating Cash Flow$ 7.51M$ 5.71M$ 2.58M$ 18.60M$ 22.72M
Investing Cash Flow-$ -239.00K$ 4.14M$ -703.00K$ -105.00K
Financing Cash Flow$ -206.00K$ -8.91M$ -10.00K$ -16.33M$ -18.95M
Currency in USD

Assertio Therapeutics Earnings and Revenue History

Assertio Therapeutics Debt to Assets

Assertio Therapeutics Cash Flow

Assertio Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis